Want better Post-op Cataract outcomes?
Consider LipiFlow treatment preoperatively.
A new study published in the American Journal of Ophthalmology investigated the effects of a preoperative LipiFlow treatment prior to cataract surgery to help alleviate MGD and dry eye induced by surgery.
Share more details about the study:
The study included 124 eyes of 124 patients, randomized to either the control group or LipiFlow treatment group.
All participants underwent exams that included meibography, tear breakup time (TBUT), and meibomian gland assessment with slit-lamp examination. After each exam, patients completed a standardized dry eye questionnaire. All participants were evaluated at the baseline visit and at 1 month and 3 months after cataract surgery. Patients in the treatment group received LipiFlow 3 weeks before cataract surgery.
What were the findings?
Eyes treated with LipiFlow prior to cataract surgery were objectively noted to have SIGNIFICANTLY IMPROVED meibomian gland patency and quality of meibum secretion, increased TBUT, and reduction in corneal staining. This data correlates well with the improved subjective outcomes reported on the dry eye questionnaire. The control group demonstrated worsening across all categories.
The Main Take Away:
These data indicate that cataract surgery can produce or aggravate MGD and increase dry eye symptoms. Performing Lipiflow prior to cataract surgery MAY ENSURE BETTER OUTCOMES with healthier ocular surface and meibomian gland objective parameters as well as subjective dry eye symptoms.